Gender-specific association of STON2 rs2371597 polymorphism in keratoconus patients of Saudi origin

Objective: To investigate the association of specific genetic polymorphisms (rs2371597 in STON2, rs11720822 in PDIA5, rs387907358 in WNT1, and rs77542162 in ABCA6) in a Saudi cohort of keratoconus (KC) patients compared to controls.

Methods: A retrospective case-control genetic association study was conducted. The study included 99 KC patients and 193 healthy controls. Genotyping was performed using real-time PCR with TaqMan assays. Associations between genetic polymorphisms and KC were assessed using various genetic models and binary logistic regression analysis.

Results: None of the tested polymorphisms showed an overall association with KC risk. Specifically, the rs2371597 polymorphism in STON2 did not demonstrate a significant association with KC risk across different genetic models. However, a gender-specific effect of rs2371597 was noted: in men, the C/G genotype was associated with a higher risk of KC, particularly in the dominant model, while no significant association was observed in women. Age and sex were identified as significant predictors of KC risk, but rs2371597 did not significantly affect KC risk in regression analysis.

Conclusion: Preliminary evidence suggests a gender-specific effect of the rs2371597 polymorphism in STON2, with an increased KC risk associated with C/G-C/C genotypes in men which was age-dependent. This result highlights the importance of considering population-specific genetic factors and the potential gender-specific effects on KC susceptibility. However, these findings need further validation with larger age- and sex-matched samples of diverse populations.

Introduction

Keratoconus (KC) is a progressive eye condition characterized by the gradual thinning and protrusion of the cornea, which distorts its normally round shape into a cone-like structure. This deformation leads to significant visual disturbances, including blurred vision, increased sensitivity to glare, and irregular astigmatism (Rabinowitz, 1998). Globally, KC affects approximately 1 in 2,000 individuals. However, prevalence rates can vary based on geographic and demographic factors. In Saudi Arabia, KC is relatively common, with estimates suggesting that it affects between 1 in 375 and 1 in 1,000 people manifesting between the early teenage years and young adulthood in most studies (Torres Netto et al., 2018; Alzahrani et al., 2021; Gordon-Shaag et al., 2015; Godefrooij et al., 2017). This higher prevalence might be attributed to specific genetic and environmental influences in the region.

The exact etiology of KC is not fully understood, but it is believed to involve a combination of environmental, biochemical and genetic factors highlighting the complex multifactorial nature of KC (Ferrari and Rama, 2020). Environmental influences such as sun exposure and mechanical stress (e.g., eye rubbing) are also associated with KC (Gordon-Shaag et al., 2015). Sex hormones have been implicated in KC and it has been noted that KC develops earlier and progresses more rapidly in men than women (Fink et al., 2005), potentially interacting with genetic predispositions to influence disease risk (Meng and Ren, 2024). There is significant interest in the genetic basis of KC because it is innate in families, indicating a hereditary component. Several genomic studies have highlighted the potential role of genetic mutations and polymorphisms in contributing to disease susceptibility and the pathogenesis of KC (Hao et al., 2021; Bykhovskaya and Rabinowitz, 2021; Song et al., 2024; Wonneberger et al., 2024; Khashim Alswailmi et al., 2023). Despite extensive research, the precise genetic determinants of KC remain elusive, making it a subject of considerable scientific interest. Investigating the genetic variants in KC is crucial to enhance our understanding of the molecular mechanisms underlying the disease and for developing potential genetic markers for early diagnosis and targeted therapeutic strategies.

Stonin 2 (STON2) gene encodes a protein crucial for intracellular transport processes, including clathrin-mediated endocytosis and vesicular trafficking. Though mainly recognized for its role in cellular transport, alterations in STON2 function can potentially contribute to neurodegenerative disorders (Luan et al., 2011; Ma et al., 2024; Mahapatra et al., 2023; Xu et al., 2018) and cancer (Mahapatra et al., 2023; Xu et al., 2018). Studies have found that the SNP rs2371597 in the STON2 gene is associated with an increased risk of developing KC and might influence cellular functions relevant to corneal structure and integrity. The polymorphism rs2371597 has been strongly associated with CCT and KC development in the Japanese and Han Chinese population (Hosoda et al., 2020; Zhang et al., 2021). Still, it has not been investigated in other ethnicities, including the Arabs of Saudi origin.

The rs11720822 polymorphism in the PDIA5 gene is associated with glaucoma due to its role in the unfolded protein response (UPR) and endoplasmic reticulum (ER) stress (Carbone et al., 2011; Ayub et al., 2014). The PDIA5 gene, encoding protein disulfide isomerase family A, member 5, is involved in protein folding and maintenance of cellular homeostasis (Villani et al., 2012). Given the overlap in pathophysiological mechanisms between glaucoma and keratoconus, including cellular stress and matrix integrity, this genetic variant might impact KC by affecting similar underlying processes. There are no studies directly linking the rs11720822 PDIA5 polymorphism to KC.

The WNT1 gene is a critical component of the Wnt signaling pathway, which regulates cell proliferation, differentiation, and migration (Yu et al., 2024). Disruptions in the Wnt pathway have been associated with various ocular diseases (Nguyen et al., 2022; Karolak et al., 2020a; Wang et al., 2024). Karolack et al. reported an accumulation of sequence variants in the Wnt signaling pathway and identified a missense variant rs387907358 (c.1063G > T, p.(V355F)) in the WNT1 gene in corneal tissue of Polish KC patients suggesting a potential role in KC (Karolak et al., 2020b). In addition, the ABCA6 gene, involved in lipid transport and metabolism, has been associated with various metabolic disorders (Kaminski et al., 2001; van Leeuwen et al., 2015). The rs77542162 variant in ABCA6 was reported to be associated with corneal biochemical properties and KC in the Europeans, suggesting its potential role in altering corneal biomechanics and structure and, thereby, in KC development (Khawaja et al., 2019).

Since the genetic etiology of KC is heterogeneous with multiple genes underlying its pathogenesis, the study aimed to investigate the association of these specific genetic polymorphisms (rs2371597 in STON2, rs11720822 in PDIA5, rs387907358 in WNT1, and rs77542162 in ABCA6) with KC in a cohort of Saudi patients. By focusing on Middle Eastern Arabs of Saudi origin, this study seeks to provide insights into the genetic basis of KC in a demographic with a unique genetic background, potentially revealing genetic risk factors and contributing to understanding this complex ocular disease in this ethnicity.

Materials and methods

Study population and design

Our retrospective case-control genetic association study adhered to the Declaration of Helsinki guidelines. We obtained written informed consent from all participants, and ethical approval from the College of Medicine Institutional Review Board (proposal number #09–659) at King Saud University in Riyadh, Saudi Arabia.

Participants included (n = 99) patients diagnosed with Keratoconus (KC) at the anterior segment clinic of King Abdulaziz University Hospital, Riyadh (Abu-Amero et al., 2014). The diagnosis was confirmed based on established clinical criteria: a Schimpff-flow-based elevation map demonstrating posterior corneal elevation within the central 5 mm of ≥ +20 μm, an inferior-to-superior (I-S) dioptric asymmetry value exceeding 1.2 diopters (D), and a steepest keratometry measurement more significant than 47 D. All participants were unrelated. Individuals were excluded if they had secondary KC resulting from trauma, surgery, Ehlers-Danlos syndrome, osteogenesis imperfecta, pellucid marginal degeneration, or if they had undergone laser-assisted in situ keratomileusis (LASIK) resulting in ectasia. Healthy control subjects (n = 193) were selected from the general ophthalmology clinic, all of the Saudi nationality, and bore no ocular diseases or history of ophthalmic surgeries. Each control participant’s corneas were clear upon examination, and their Schimpff-flow-based elevation maps displayed normal findings. Control subjects who opted not to participate were also excluded from the study (Abu-Amero et al., 2014).

DNA preparation and genotyping

Peripheral EDTA blood was used for DNA extraction using the QIAamp DNA Mini Kit as per the manufacturer’s instructions (Cat. No. 51306, Qiagen, Hilden, Germany). For genotyping, commercially available TaqMan^® genotyping assay mix (Cat. No.: 4331349; Applied Biosystems Inc., Foster City, CA, USA) was used–rs2371597 in STON2 (Assay ID: C___2791741_10), rs11720822 in PDIA5 (C__11238237_10), rs387907358 in WNT1 (C_322377343_10), and rs77542162 in ABCA6 (C_102267712_10) according to the manufacturer’s protocol for real-time PCR (ABI-7500, Applied Biosystems) as described previously (Kondkar et al., 2022). Genotype calling was performed using the allele discrimination software version 2.0.5 in ABI-7500. Polymorphism details are shown in Table 1.

Table 1

Table 1. Details of the polymorphisms investigated in this study.

Statistical analysis

For the current study, continuous variables were analyzed using the Mann–Whitney U-test following normality assessments by the Kolmogorov–Smirnov test. The Hardy–Weinberg equilibrium (HWE) deviation and genetic associations with KC was tested using Chi-square and Fisher’s exact tests as appropriate. The influence of risk factors—including age, sex, and genotype—on KC was assessed through binary logistic regression analysis. All statistical analyses were conducted using SPSS software, version 25 (IBM Inc., Chicago, IL, USA) and SNPStats online version 1.0, accessible at SNPStats (https://www.snpstats.net/start.htm accessed on 14 August 2024). Power calculation was performed using the stand-alone PS program version 3.1.6. A significant threshold p-value was set at less than 0.05. Risk estimates were reported as odds ratios (OR) with 95% confidence intervals (CI).

Results

The demographic analysis revealed a notable age difference between the control and KC patient groups, with controls being significantly older, ranging from 35 to 75 years (average age 59.0 years) compared to younger KC patients ranging from 12 to 45 years (average age 25.9 years), as indicated by a p-value of <0.001 (Table 2). In contrast, the gender distribution between the two study groups was similar and showed no significant difference (p = 0.3142) (Table 2).

Table 2

Table 2. Demographic characteristics and distribution of minor allele frequency of investigated polymorphisms in Keratoconus patient and control participants.

Regarding the minor allele frequencies (MAFs) and their association with KC, none of the tested polymorphisms showed an allelic connection to the disease (Table 2). The allele frequency for rs2371597 [C] in STON2 was similar between controls (0.38) and KC patients (0.39), and the odds ratio (1.05) with a p-value of 0.7643 suggests no significant association with KC. The rs11720822 [T] variant in PDIA5 showed a low frequency in controls (0.02) and was absent in KC patients with a p-value of 0.1013, indicating no potential association with KC. Also, rs387907358 [T] and rs77542162 [G] variants in WNT1 and ABCA6 were absent in either group. Hence, further statistical analysis was performed only for rs2371597 STON2 polymorphism. Overall, these results imply that the allele frequency of the studied polymorphisms is not associated with KC.

The overall genotype analysis of the rs2371597 polymorphism in the STON2 gene showed that this genetic variant is not significantly associated with KC risk across different genetic models (Table 3). In the codominant model, the odds ratios for genotypes G/G, C/G, and C/C were close to 1, indicating no notable difference in KC risk compared to the wild-type G/G genotype. Similarly, the dominant model (G/G vs C/G-C/C) and recessive model (G/G-C/G vs C/C) also showed no significant associations, with p-values greater than the significant threshold of 0.05.

Table 3

Table 3. Genotype association analysis of polymorphisms rs2371597 in STON2 with the risk of keratoconus compared to controls under different genetic models and according to gender.

In contrast, gender-specific genotype analyses revealed an interesting finding. In men, the C/G genotype was associated with a significantly increased risk of KC, particularly evident in the dominant model (OR 2.05, p = 0.042), suggesting a potential gender-specific effect (Table 3). However, women showed no association between rs2371597 and KC risk across any genetic model. However, there were non-significant trends towards decreased risk with the C/G genotype in the codominant and dominant models. These results imply that while rs2371597 may not broadly impact KC risk, it could have a gender-specific influence in men, warranting further investigation.

The binary logistic regression analysis (Table 4) showed that age was a significant predictor of KC risk. Age was inversely related to KC risk, with each additional year of age associated with a 19% decrease in risk, as indicated by an odds ratio of 0.81 and a highly significant p-value of 0.000. However, it is noteworthy that since KC typically manifests during puberty or early adulthood, the KC participants were significantly younger than the controls. Likewise, sex was also a significant predictor of KC, with females having about 75% lower odds of developing KC compared to males, as reflected in the odds ratio of 0.25 and a p-value of 0.035. In contrast, the rs2371597 polymorphism showed no significant association with KC risk in the codominant or dominant models. The OR for the C/G and C/C genotypes and the combined model of C/G + C/C versus G/G were close to 1 with non-significant p-values of 0.455, 0.678, and 0.451 respectively. This finding suggests that the variant rs2371597 does not significantly influence the risk of KC and the observed gender-effect of the polymorphism in men is likely to be dependent on age. Thus, an age- and sex-matched case-control study in a large cohort would be needed to confirm these findings.

Table 4

Table 4. Binary logistic regression analysis to determine the effect of age, sex, and polymorphisms rs2371597 in codominant and dominant models on the risk of keratoconus.

Discussion

This study investigated the association of specific genetic polymorphisms in the STON2, PDIA5, WNT1, and ABCA6 genes with KC in a Saudi cohort. While our findings did not reveal strong overall associations between these polymorphisms and KC risk, we identified a noteworthy gender-specific effect linked to the rs2371597 polymorphism in STON2.

KC, characterized by progressive corneal thinning and distortion, poses significant visual impairment challenges. The heterogeneous nature of its etiology suggests that genetic factors may vary widely across populations (Hao et al., 2021; Bykhovskaya and Rabinowitz, 2021). Previous studies, particularly in Japanese and Han Chinese cohorts, reported a strong association between the STON2 rs2371597 polymorphism and KC (Hosoda et al., 2020; Zhang et al., 2021). Our findings, however, highlight a different dynamic in the Saudi population. The MAF of rs2371597(C) in the KC Saudi cohort (0.39) was slightly higher than the Japanese (0.30) and Han Chinese (0.35). Although we did not observe a general association with KC across the cohort, the gender-specific result in men indicates that this polymorphism may contribute to susceptibility in specific subgroups. Specifically, men with the C/G genotype exhibited a significantly higher risk of developing KC, suggesting potential interactions between genetic and hormonal factors that influence disease manifestation. For example, androgens have been shown to impact corneal healing and epithelial integrity, which may render males more susceptible to developing KC when coupled with genetic predispositions (McKay et al., 2022; Nuzzi and Caselgrandi, 2022). Furthermore, lifestyle factors and environmental exposures may differ by sex, potentially affecting the manifestation of genetic risk factors.

The rs2371597 polymorphism in STON2 may influence KC through several biological mechanisms. STON2 is involved in intracellular transport processes, including clathrin-mediated endocytosis and vesicular trafficking (Willox and Royle, 2012; Jung et al., 2007). Disruption in these processes could affect cellular homeostasis and corneal cell function. Notably, the involvement of microRNA (miRNA), miRNA-875-3p, in regulating STON2 expression could also play a crucial role (Wang et al., 2020). MiRNAs can modulate gene expression post-transcriptionally, potentially affecting corneal integrity and susceptibility to KC (Zhang et al., 2022). For instance, the altered expression of STON2, potentially influenced by both genetic factors like the rs2371597 polymorphism and regulatory miRNAs such as miRNA-875-3p, might lead to impaired endocytic processes, exacerbating corneal cell stress and contribute to KC pathogenesis (Hao et al., 2021).

Additionally, STON2 interacts with various signaling pathways, including those related to cellular stress responses (Ma et al., 2024; Mahapatra et al., 2023; Xu et al., 2018). Given the shared pathological features between KC and other ocular conditions, alterations in STON2 could intersect with signaling pathways involved in keratocyte apoptosis and extracellular matrix remodeling, which are pivotal in KC development (Hao et al., 2021). Given the complex etiology of KC, it is possible that different environmental factors might interact with genetic predispositions and increase KC risk (Bykhovskaya and Rabinowitz, 2021). Accordingly, it can be speculated that abnormal collagen synthesis due to hormonal influence (McKay et al., 2022; Zhao et al., 2022), disruption of corneal extracellular matrix homeostasis or intracellular protein trafficking plausibly through miRNA due to rs2371597 polymorphism in STON2 gene (Hosoda et al., 2020; Zhang et al., 2022) combined with age factor may help explain why the young males in our KC cohort are more susceptible to KC, highlighting the complex interplay of different biological and genetic factors may work together to affect the risk of KC.

Although STON2 can be hypothesized to have an indirect role in KC development or progression through the speculated mechanism(s) discussed above, however, our study does not provide any functional or mechanistic evidence and future studies are needed to explore the consequences of the STON2 rs2371597 polymorphism in KC pathogenesis. Besides, future research should also explore potential epistatic and gene-environment interactions to better understand how these polymorphisms influence KC risk in different settings.

The low allele frequency or absence of the rs11720822 [T] variant in PDIA5 and the rs387907358 [T] and rs77542162 [G] variants in WNT1 and ABCA6, respectively, among KC patients of Saudi origin suggests that these particular variants might not be significant risk factors for KC in Saudi individuals. Several factors might be attributed to the lack of significant associations for the polymorphisms rs11720822 in PDIA5, rs387907358 in WNT1, and rs77542162 in ABCA6. One key factor is population-specific genetic variability, where genetic variants can differ in frequency across populations due to historical and evolutionary influences. The results imply that these variants may be rare or absent in the Saudi population due to unique genetic drift or founder effects. As a result, the allelic frequencies and functional impacts of these polymorphisms might vary in the Saudi population compared to those observed in previous studies involving European or Asian cohorts (Ayub et al., 2014; Karolak et al., 2020b; Khawaja et al., 2019). This finding highlights the importance of considering population diversity when assessing genetic risk factors for diseases like KC.

The study has few limitations and the results require a cautious interpretation. The sample size examined in this study is relatively small, with even fewer numbers in subgroup analyses, particularly in the gender-stratified analysis. Nonetheless, our study exhibited power of 0.8 to detect significant associations between KC and rs2371597 STON2 polymorphism for an OR of 2.0 and α (Type I error) of 0.05. Also, since ours is a tertiary care center there could be a referral or selection bias in the study and may not reflect the general Saudi population. Besides, the study lacks any mechanistic evidence to demonstrate the role of STON2 polymorphism rs2371597 in KC. Therefore, further multi-center genetic research with larger and more diverse cohorts is essential to elucidate the genetic underpinnings of KC.

In conclusion, this study did not find strong associations between the investigated genetic polymorphisms and KC risk in the Saudi cohort. However, there is some evidence to suggest a gender-specific effect of rs2371597 polymorphism in the STON2 towards increased risk of KC, particularly in men, indicating that genetic predispositions may interact with hormonal and/or environmental factors in this population. But, these findings are preliminary, and future research is needed to replicate these findings in large age- and sex-matched independent cohorts and diverse populations to elucidate the biological mechanisms through which this polymorphism might influence KC risk, particularly its gender-specific effects. Further investigation of the mechanisms underlying the complex interplay between age, genetics, and gender may help elucidate the overall disease risk profile. Finally, this study adds to the growing body of literature on the genetic basis of KC that may aid in developing targeted prevention and treatment strategies.

Data availability statement

The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.

Ethics statement

The studies involving humans were approved by Institutional Review Board Committee of the College of Medicine, King Saud University. The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation in this study was provided by the participant’s legal guardians/next of kin.

Author contributions

AK: Conceptualization, Formal Analysis, Investigation, Methodology, Supervision, Writing–original draft, Writing–review and editing. TS: Data curation, Investigation, Methodology, Writing–review and editing. TA: Data curation, Investigation, Methodology, Writing–review and editing. TK: Data curation, Resources, Writing–review and editing. GL: Data curation, Resources, Writing–review and editing. HK: Conceptualization, Resources, Writing–review and editing. SA-O: Conceptualization, Project administration, Resources, Writing–review and editing. AA-M: Conceptualization, Project administration, Resources, Writing–review and editing.

Funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by King Saud University through the Vice Deanship of Scientific Research Chair and Glaucoma Research Chair in Ophthalmology (GRC-2024).

Acknowledgments

The authors would like to express their appreciation to Al-Sheikh Ibrahim Al-Sultan for his valuable support and to Abdulrahman Al-Mosa for his clinical assistance during the study.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The author(s) declare that no Generative AI was used in the creation of this manuscript.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

Abu-Amero, K. K., Kondkar, A. A., Azad, T. A., Sultan, T., Kalantan, H., and Al-Muammar, A. M. (2014). Keratoconus is associated with increased copy number of mitochondrial DNA. Mol. Vis. 20, 1203–1208.

PubMed Abstract | Google Scholar

Alzahrani, K., Al-Rashah, A., Al-Salem, S., Al-Murdif, Y., Al-Rashah, A., Alrashah, A., et al. (2021). Keratoconus epidemiology presentations at najran province, Saudi Arabia. Clin. Optom. 13, 175–179. doi:10.2147/OPTO.S309651

PubMed Abstract | CrossRef Full Text | Google Scholar

Ayub, H., Micheal, S., Akhtar, F., Khan, M. I., Bashir, S., Waheed, N. K., et al. (2014). Association of a polymorphism in the BIRC6 gene with pseudoexfoliative glaucoma. PloS One 9, e105023. doi:10.1371/journal.pone.0105023

PubMed Abstract | CrossRef Full Text | Google Scholar

Bykhovskaya, Y., and Rabinowitz, Y. S. (2021). Update on the genetics of keratoconus. Exp. Eye Res. 202, 108398. doi:10.1016/j.exer.2020.108398

PubMed Abstract | CrossRef Full Text | Google Scholar

Carbone, M. A., Chen, Y., Hughes, G. A., Weinreb, R. N., Zabriskie, N. A., Zhang, K., et al. (2011). Genes of the unfolded protein response pathway harbor risk alleles for primary open angle glaucoma. PloS One 6, e20649. doi:10.1371/journal.pone.0020649

PubMed Abstract | CrossRef Full Text | Google Scholar

Ferrari, G., and Rama, P. (2020). The keratoconus enigma: a review with emphasis on pathogenesis. Ocul. Surf. 18, 363–373. doi:10.1016/j.jtos.2020.03.006

PubMed Abstract | CrossRef Full Text | Google Scholar

Fink, B. A., Wagner, H., Steger-May, K., Rosenstiel, C., Roediger, T., McMahon, T. T., et al. (2005). Differences in keratoconus as a function of gender. Am. J. Ophthalmol. 140, 459–468. doi:10.1016/j.ajo.2005.03.078

PubMed Abstract | CrossRef Full Text | Google Scholar

Godefrooij, D. A., de Wit, G. A., Uiterwaal, C. S., Imhof, S. M., and Wisse, R. P. L. (2017). Age-specific incidence and prevalence of keratoconus: a nationwide registration study. Am. J. Ophthalmol. 175, 169–172. doi:10.1016/j.ajo.2016.12.015

PubMed Abstract | CrossRef Full Text | Google Scholar

Gordon-Shaag, A., Millodot, M., Shneor, E., and Liu, Y. (2015). The genetic and environmental factors for keratoconus. Biomed. Res. Int. 2015, 795738. doi:10.1155/2015/795738

PubMed Abstract | CrossRef Full Text | Google Scholar

Hao, X.-D., Gao, H., Xu, W.-H., Shan, C., Liu, Y., Zhou, Z.-X., et al. (2021). Systematically displaying the pathogenesis of keratoconus via multi-level related gene enrichment-based review. Front. Med. 8, 770138. doi:10.3389/fmed.2021.770138

PubMed Abstract | CrossRef Full Text | Google Scholar

Hosoda, Y., Miyake, M., Meguro, A., Tabara, Y., Iwai, S., Ueda-Arakawa, N., et al. (2020). Keratoconus-susceptibility gene identification by corneal thickness genome-wide association study and artificial intelligence IBM Watson. Commun. Biol. 3, 410. doi:10.1038/s42003-020-01137-3

PubMed Abstract | CrossRef Full Text | Google Scholar

Jung, N., Wienisch, M., Gu, M., Rand, J. B., Müller, S. L., Krause, G., et al. (2007). Molecular basis of synaptic vesicle cargo recognition by the endocytic sorting adaptor stonin 2. J. Cell Biol. 179, 1497–1510. doi:10.1083/jcb.200708107

PubMed Abstract | CrossRef Full Text | Google Scholar

Kaminski, W. E., Wenzel, J. J., Piehler, A., Langmann, T., and Schmitz, G. (2001). ABCA6, a novel a subclass ABC transporter. Biochem. Biophys. Res. Commun. 285, 1295–1301. doi:10.1006/bbrc.2001.5326

PubMed Abstract | CrossRef Full Text | Google Scholar

Karolak, J. A., Gambin, T., Rydzanicz, M., Polakowski, P., Ploski, R., Szaflik, J. P., et al. (2020b). Accumulation of sequence variants in genes of Wnt signaling and focal adhesion pathways in human corneas further explains their involvement in keratoconus. PeerJ 8, e8982. doi:10.7717/peerj.8982

PubMed Abstract | CrossRef Full Text | Google Scholar

Karolak, J. A., Ginter-Matuszewska, B., Tomela, K., Kabza, M., Nowak-Malczewska, D. M., Rydzanicz, M., et al. (2020a). Further evaluation of differential expression of keratoconus candidate genes in human corneas. PeerJ 8, e9793. doi:10.7717/peerj.9793

PubMed Abstract | CrossRef Full Text | Google Scholar

Khashim Alswailmi, F., Bokhari, K., Aladaileh, S. H., A Alanezi, A., Azam, M., and Ahmad, A. (2023). Protective and pathogenic role of collagen subtypes genes COL4A3 and COL4A4 polymorphisms in the onset of keratoconus in South-Asian Pakistani cohort. Saudi J. Biol. Sci. 30, 103503. doi:10.1016/j.sjbs.2022.103503

PubMed Abstract | CrossRef Full Text | Google Scholar

Khawaja, A. P., Rojas Lopez, K. E., Hardcastle, A. J., Hammond, C. J., Liskova, P., Davidson, A. E., et al. (2019). Genetic variants associated with corneal biomechanical properties and potentially conferring susceptibility to keratoconus in a genome-wide association study. JAMA Ophthalmol. 137, 1005–1012. doi:10.1001/jamaophthalmol.2019.2058

PubMed Abstract | CrossRef Full Text | Google Scholar

Kondkar, A. A., Sultan, T., Azad, T. A., Osman, E. A., Almobarak, F. A., Lobo, G. P., et al. (2022). Evaluation of ABCA1 and FNDC3B gene polymorphisms associated with pseudoexfoliation glaucoma and primary angle-closure glaucoma in a Saudi cohort. Front. Genet. 13, 877174. doi:10.3389/fgene.2022.877174

PubMed Abstract | CrossRef Full Text | Google Scholar

Luan, Z., Zhang, Y., Lu, T., Ruan, Y., Zhang, H., Yan, J., et al. (2011). Positive association of the human STON2 gene with schizophrenia. Neuroreport 22, 288–293. doi:10.1097/WNR.0b013e328345ac22

PubMed Abstract | CrossRef Full Text | Google Scholar

Ma, Y., Gao, K., Sun, X., Wang, J., Yang, Y., Wu, J., et al. (2024). STON2 variations are involved in synaptic dysfunction and schizophrenia-like behaviors by regulating Syt1 trafficking. Sci. Bull. 69, 1458–1471. doi:10.1016/j.scib.2024.02.013

PubMed Abstract | CrossRef Full Text | Google Scholar

Mahapatra, K. K., Mishra, S. R., Dhiman, R., and Bhutia, S. K. (2023). Stonin 2 activates lysosomal-mTOR axis for cell survival in oral cancer. Toxicol. Vitro Int. J. Publ. Assoc. BIBRA 88, 105561. doi:10.1016/j.tiv.2023.105561

CrossRef Full Text | Google Scholar

McKay, T. B., Priyadarsini, S., and Karamichos, D. (2022). Sex hormones, growth hormone, and the cornea. Cells 11, 224. doi:10.3390/cells11020224

PubMed Abstract | CrossRef Full Text | Google Scholar

Meng, F., and Ren, S. (2024). Identification of hub genes and molecular pathways in keratoconus by integrating bioinformatics and literature mining at the RNA level. Int. Ophthalmol. 44, 244. doi:10.1007/s10792-024-03071-3

PubMed Abstract | CrossRef Full Text | Google Scholar

Nguyen, H., Lee, S.-J., and Li, Y. (2022). Selective activation of the wnt-signaling pathway as a novel therapy for the treatment of diabetic retinopathy and other retinal vascular diseases. Pharmaceutics 14, 2476. doi:10.3390/pharmaceutics14112476

PubMed Abstract | CrossRef Full Text | Google Scholar

Nuzzi, R., and Caselgrandi, P. (2022). Sex hormones and their effects on ocular disorders and pathophysiology: current aspects and our experience. Int. J. Mol. Sci. 23, 3269. doi:10.3390/ijms23063269

PubMed Abstract | CrossRef Full Text | Google Scholar

Rabinowitz, Y. S. (1998). Keratoconus. Surv. Ophthalmol. 42, 297–319. doi:10.1016/s0039-6257(97)00119-7

CrossRef Full Text

Song, C., Li, L., Liu, C., Hu, L., Bai, J., Liang, W., et al. (2024). Whole-exome sequencing screening for candidate genes and variants associated with primary sporadic keratoconus in Chinese patients. Exp. Eye Res. 245, 109978. doi:10.1016/j.exer.2024.109978

PubMed Abstract | CrossRef Full Text | Google Scholar

Torres Netto, E. A., Al-Otaibi, W. M., Hafezi, N. L., Kling, S., Al-Farhan, H. M., Randleman, J. B., et al. (2018). Prevalence of keratoconus in paediatric patients in Riyadh, Saudi Arabia. Br. J. Ophthalmol. 102, 1436–1441. doi:10.1136/bjophthalmol-2017-311391

PubMed Abstract | CrossRef Full Text | Google Scholar

van Leeuwen, E. M., Karssen, L. C., Deelen, J., Isaacs, A., Medina-Gomez, C., Mbarek, H., et al. (2015). Genome of The Netherlands population-specific imputations identify an ABCA6 variant associated with cholesterol levels. Nat. Commun. 6, 6065. doi:10.1038/ncomms7065

PubMed Abstract | CrossRef Full Text | Google Scholar

Villani, G. R. D., Chierchia, A., Di Napoli, D., and Di Natale, P. (2012). Unfolded protein response is not activated in the mucopolysaccharidoses but protein disulfide isomerase 5 is deregulated. J. Inherit. Metab. Dis. 35, 479–493. doi:10.1007/s10545-011-9403-8

PubMed Abstract | CrossRef Full Text | Google Scholar

Wang, Q., Xue, J., Ren, Q., Li, X., and Qiu, X. (2020). Long-chain non-coding RNA GACAT1 promotes development and progression of breast cancer by targeting microRNA-875-3p. Oncol. Lett. 19, 2547–2553. doi:10.3892/ol.2020.11260

PubMed Abstract | CrossRef Full Text | Google Scholar

Wang, Y., Ge, H., Chen, P., and Wang, Y. (2024). Wnt/β-catenin signaling in corneal epithelium development, homeostasis, and pathobiology. Exp. Eye Res. 246, 110022. doi:10.1016/j.exer.2024.110022

PubMed Abstract | CrossRef Full Text | Google Scholar

Willox, A. K., and Royle, S. J. (2012). Stonin 2 is a major adaptor protein for clathrin-mediated synaptic vesicle retrieval. Curr. Biol. CB 22 (22), 1435–1439. doi:10.1016/j.cub.2012.05.048

PubMed Abstract | CrossRef Full Text | Google Scholar

Wonneberger, W., Sterner, B., MacLean, U., Claesson, M., Johansson, L. H., Skoog, I., et al. (2024). Genetic variants in the FOXO1 and ZNF469 genes are associated with keratoconus in Sweden: a case-control study. BMC Ophthalmol. 24, 36. doi:10.1186/s12886-024-03299-8

PubMed Abstract | CrossRef Full Text | Google Scholar

Xu, S., Yue, Y., Zhang, S., Zhou, C., Cheng, X., Xie, X., et al. (2018). STON2 negatively modulates stem-like properties in ovarian cancer cells via DNMT1/MUC1 pathway. J. Exp. Clin. Cancer Res. 37, 305. doi:10.1186/s13046-018-0977-y

PubMed Abstract | CrossRef Full Text | Google Scholar

Yu, M., Qin, K., Fan, J., Zhao, G., Zhao, P., Zeng, W., et al. (2024). The evolving roles of Wnt signaling in stem cell proliferation and differentiation, the development of human diseases, and therapeutic opportunities. Genes Dis. 11, 101026. doi:10.1016/j.gendis.2023.04.042

PubMed Abstract | CrossRef Full Text | Google Scholar

Zhang, J., Li, Y., Dai, Y., and Xu, J. (2021). Evaluating the association between single nucleotide polymorphisms in the stonin 2 (STON2) gene and keratoconus in a Han Chinese population. Ann. Transl. Med. 9, 616. doi:10.21037/atm-20-6654

PubMed Abstract | CrossRef Full Text | Google Scholar

Zhang, Y., Che, D., Cao, Y., Yue, Y., He, T., Zhu, Y., et al. (2022). MicroRNA profiling in the aqueous humor of keratoconus eyes. Transl. Vis. Sci. Technol. 11, 5. doi:10.1167/tvst.11.12.5

PubMed Abstract | CrossRef Full Text | Google Scholar

Zhao, X., Yuan, Y., Sun, T., Zhang, Y., and Chen, Y. (2022). Associations between keratoconus and the level of sex hormones: a cross-sectional study. Front. Med. 9, 828233. doi:10.3389/fmed.2022.828233

PubMed Abstract | CrossRef Full Text | Google Scholar